High Potency API Contract Manufacturing Market · GlobeNewswire Inc. Dublin, Nov. 14, 2024 (GLOBE NEWSWIRE) -- The "High Potency API Contract Manufacturing Market Size, Share & Trends Analysis by ...
Global High Potency API CDMOs Market: Innovations in Manufacturing Technology Fueling Growth by 2027
The Global High Potency API CDMOs Market is expected to witness a high and a single-digit growth by 2027. The principal factors fueling the market’s growth are growing demand for oncology medications, ...
The global biotech API manufacturing services market, valued at US$ 38.9 Billion in 2022, is projected to grow at a CAGR of 7.1% from 2023 to 2031, surpassing US$ 73 Billion by 2031. biotech API ...
PHILADELPHIA & LONDON--(BUSINESS WIRE)--Ori Biotech, a leader in cell and gene therapy (CGT) manufacturing technology, today announced that the IRO® platform has received Advanced Manufacturing ...
(MENAFN- IMARC Group) An API (Active Pharmaceutical Ingredient) is the biologically active component of a drug that produces the intended therapeutic effect. It is the essential substance in medicines ...
The global high potency API contract manufacturing market, valued at USD 8 billion in 2022, is poised for robust growth, with projections to reach USD 16 billion by 2032. This remarkable expansion, ...
Saharsh Davuluri, Neuland Labs, urges API and peptide automation by 2026 to match modern biologics standards. PharmTech recently spoke with Saharsh Davuluri, Vice Chairman and Managing Director, ...
AbbVie’s North Chicago expansion adds two state-of-the-art API plants intended to support next-generation neuroscience and obesity portfolios via advanced manufacturing technologies and artificial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results